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Abstract: BACKGROUND: Coronary computed tomography angiography has become the foremost non-
invasive imaging modality of the coronary arteries and is used as an alternative to the reference standard,
conventional coronary angiography, for direct visualization and detection of coronary artery stenoses in
patients with suspected coronary artery disease. Nevertheless, there is considerable debate regarding
the optimal target population to maximize clinical performance and patient benefit. The most obvious
indication for noninvasive coronary computed tomography angiography in patients with suspected coro-
nary artery disease would be to reliably exclude significant stenosis and, thus, avoid unnecessary invasive
conventional coronary angiography. To do this, a test should have, at clinically appropriate pretest like-
lihoods, minimal false-negative outcomes resulting in a high negative predictive value. However, little is
known about the influence of patient characteristics on the clinical predictive values of coronary com-
puted tomography angiography. Previous regular systematic reviews and meta-analyses had to rely on
limited summary patient cohort data offered by primary studies. Performing an individual patient data
meta-analysis will enable a much more detailed and powerful analysis and thus increase representative-
ness and generalizability of the results. The individual patient data is registered with the PROSPERO
database (CoMe-CCT, CRD42012002780). METHODS: The analysis will include individual patient data
from published and unpublished prospective diagnostic accuracy studies comparing coronary computed
tomography angiography with conventional coronary angiography. These studies will be identified per-
forming a systematic search in several electronic databases. Corresponding authors will be contacted
and asked to provide obligatory and additional data. Risk factors, previous test results and symptoms of
individual patients will be used to estimate the pretest likelihood of coronary artery disease. A bivariate
random-effects model will be used to calculate pooled mean negative and positive predictive values as well
as sensitivity and specificity. The primary outcome of interest will be positive and negative predictive
values of coronary computed tomography angiography for the presence of coronary artery disease as a
function of pretest likelihood of coronary artery disease, analyzed by meta-regression. As a secondary
endpoint, factors that may influence the diagnostic performance and clinical value of computed tomog-
raphy, such as heart rate and body mass index of patients, number of detector rows, and administration
of beta blockade and nitroglycerin, will be investigated by integrating them as further covariates into the
bivariate random-effects model. DISCUSSION: This collaborative individual patient data meta-analysis
should provide answers to the pivotal question of which patients benefit most from noninvasive coronary
computed tomography angiography and thus help to adequately select the right patients for this test.
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Abstract
Background: Coronary computed tomography angiography has become the foremost noninvasive imaging
modality of the coronary arteries and is used as an alternative to the reference standard, conventional coronary
angiography, for direct visualization and detection of coronary artery stenoses in patients with suspected coronary
artery disease. Nevertheless, there is considerable debate regarding the optimal target population to maximize
clinical performance and patient benefit. The most obvious indication for noninvasive coronary computed
tomography angiography in patients with suspected coronary artery disease would be to reliably exclude
significant stenosis and, thus, avoid unnecessary invasive conventional coronary angiography. To do this, a test
should have, at clinically appropriate pretest likelihoods, minimal false-negative outcomes resulting in a high
negative predictive value. However, little is known about the influence of patient characteristics on the clinical
predictive values of coronary computed tomography angiography. Previous regular systematic reviews and meta-
analyses had to rely on limited summary patient cohort data offered by primary studies. Performing an individual
patient data meta-analysis will enable a much more detailed and powerful analysis and thus increase
representativeness and generalizability of the results. The individual patient data meta-analysis is registered with the
PROSPERO database (CoMe-CCT, CRD42012002780).
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Methods/Design: The analysis will include individual patient data from published and unpublished prospective
diagnostic accuracy studies comparing coronary computed tomography angiography with conventional coronary
angiography. These studies will be identified performing a systematic search in several electronic databases.
Corresponding authors will be contacted and asked to provide obligatory and additional data. Risk factors, previous
test results and symptoms of individual patients will be used to estimate the pretest likelihood of coronary artery
disease. A bivariate random-effects model will be used to calculate pooled mean negative and positive predictive
values as well as sensitivity and specificity. The primary outcome of interest will be positive and negative predictive
values of coronary computed tomography angiography for the presence of coronary artery disease as a function of
pretest likelihood of coronary artery disease, analyzed by meta-regression. As a secondary endpoint, factors that
may influence the diagnostic performance and clinical value of computed tomography, such as heart rate and
body mass index of patients, number of detector rows, and administration of beta blockade and nitroglycerin, will
be investigated by integrating them as further covariates into the bivariate random-effects model.
Discussion: This collaborative individual patient data meta-analysis should provide answers to the pivotal question
of which patients benefit most from noninvasive coronary computed tomography angiography and thus help to
adequately select the right patients for this test.
Keywords: Collaborative meta-analysis on cardiac CT, CoMe-CCT, Coronary CT angiography, Individual patient data
meta-analysis, IPD, Positive and negative predictive value, Pretest likelihood, Sensitivity and specificity, Study
protocol
Background
Coronary artery disease (CAD) is the main cause of
death in industrialized countries [1]. To allow early
detection as well as accurately ruling out CAD, a reliable
noninvasive test would have important advantages. To
reliably exclude disease, a diagnostic test with a minimal
proportion of false-negative results and thus a relatively
high sensitivity should be used [2]. Coronary computed
tomography (CT) angiography has already been evaluated
comprehensively concerning its diagnostic accuracy
potentials by single studies and meta-analyses. However,
the influence of the clinical presentation, risk factors and
prior test results of patients, which can be used to estimate
the influence of the pretest likelihood of CAD on the posi-
tive and negative predictive values of coronary CT angiog-
raphy, are not fully understood. A few single-center studies
have been published dealing with the influence of the
pretest likelihood of CAD on the diagnostic performance of
CT. Meijboom et al. demonstrated in 254 symptomatic
patients that the accuracy of coronary CT angiography was
greatest in patients with low-to-intermediate pretest likeli-
hood whereas the negative predictive value was substan-
tially reduced in patients with high pretest likelihood [3].
This reduction of the negative predictive values in patients
with high disease prevalence was also shown in a compar-
able study by Husmann et al. comprising 88 patients [4]. In
90 patients, Leber et al. also demonstrated that CT allows
CAD to be accurately ruled out if an intermediate pretest
likelihood is present [5]. Applying Bayesian analysis, Dewey
et al. [6] confirmed that the diagnostic performance of both
CT and magnetic resonance coronary angiography was
influenced by the pretest likelihood. Pretest likelihood of
CAD can be estimated according to clinical presentation
and risk factors applying several tabulation tools [7-11] and
the appropriateness of further testing may be estimated
based on their results. Establishing and further elucidating
the potential of pretest likelihood estimations to ensure
the appropriateness of CT is an important aim of cardio-
vascular medicine. In a meta-regression analysis using
disease prevalence as a surrogate marker for pretest likeli-
hood, Schlattmann et al. further specified the boundaries
of low-to-intermediate pretest likelihood for patients in
whom coronary CTangiography can be applied as a reliable
rule-out test [12] (Figure 1).
The analysis is based on summary patient collective
data from primary study articles aggregated in a regular
meta-analysis [13] and, thus, further specific patient-level
information for more detailed subanalyses were not
available.
The purpose and main aim of this project is thus to
summarize the published and unpublished evidence on
coronary CT angiography using IPD in a collaborative
meta-analysis to draw more reliable and generalizable
conclusions [14] concerning the appropriateness of CT
in patients with varying presentations and thus pretest
likelihoods [15]. The results should enable us to determine
which patients benefit most from noninvasive coronary
angiography and those less suited to undergo CT.
Moreover, the influence of additional patient and
acquisition characteristics will also be summarized in
our collaborative meta-analysis to allow us to draw
important conclusions concerning the eligibility of patients
for coronary CTangiography and the importance of specific
technical requirements and methods of preparation.
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Among these factors being discussed or having previously
been shown to influence the diagnostic performance of
coronary CT angiography is the heart rate of the patients
during scanning, which may lead to motion artifacts, and
the body mass index, which, if severely increased, can
result in rather noisy nondiagnostic test results [16-18].
Also, technical factors such as the number of simultaneous
CT detector rows and the administration of beta blockade
to reduce heart rate and nitroglycerin to dilate the vessels
have been shown in single-center studies to alter the
diagnostic performance and image quality of coronary
CT angiography [19-24]. In detail, subanalyses will be
performed to investigate the following questions:
• Is there a decrease in diagnostic accuracy of coronary
CT angiography in patients with a body mass index >30?
• Does heart rate control (heart rate <60 beats per
minute) lead to an increase of accuracy?
• Does the use of ≥64-row CTs lead to an increase of
diagnostic accuracy?
• Is there a difference in diagnostic accuracy between
men and women after adjusting for differences in
pretest likelihood?
• Is diagnostic accuracy higher in patients >70 years of
age or younger patients after adjusting for differences
in calcium score?
• Is a certain Agatston calcium score threshhold a good
universal predictor for coronary artery disease?
• Is diagnostic accuracy of CT different in patients with
atypical or typical chest pain?
This IPD meta-analysis will enable us to perform the
main and secondary analyses on an individual per-patient
basis, the clinically most relevant level of analysis. The
results may have relevant clinical implications because con-
ventional coronary angiography (CCA) exposes the patients
to infrequent yet considerable risks, such as myocardial
infarction, coronary artery dissection and ventricular tachy-
cardia [25,26], which might be avoided using CT in selected
patient populations with suspected CAD. In addition, there
are also economic considerations because CT might also be
more cost effective [27].
Methods/Design
This is a study protocol for the collaborative IPD meta-
analysis on coronary CT angiography in comparison to
Figure 1 Predictive values of coronary computed tomography angiography. The population-averaged predictive values (based on
published studies and their summary results) are shown as blue (positive) and green (negative) curves with their 95% confidence intervals based
on the published studies (circles). The negative predictive values are shown as 1-negative predictive values to avoid overlap with the positive
predictive value curve. The number of patients included in the published studies is indicated by the size of the circles. The dashed lines indicate
the predefined minimal predictive values on the y-axis (90% for negative and 70% for the positive predictive values). Such analyses are limited
because only the published predictive values in the studies and the calculated prevalences (but not the pretest likelihoods [7-9]) are available.
Thus, individual patient data (IPD) from a collaborative meta-analysis can overcome these limitations and draw more meaningful conclusions
about the clinical utility of diagnostic tests. Image reproduced from: Schlattmann P, Schuetz GM, Dewey M: Influence of coronary artery disease
prevalence on predictive values of coronary CT angiography: a meta-regression analysis. Eur Radiol 2011, 21(9):1904–1913 [12].
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conventional angiography as the gold standard, called
Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT).
It was registered with the PROSPERO database [28,29]
(registration number: CRD42012002780). This collaborative
IPD meta-analysis is exempt from ethical approval as the
analysis as well as the results for publication only involve
de-identified data and all individual studies that will be
summarized have received local ethics approval.
Identifying eligible studies for CoMe-CCT
Valid published and unpublished studies will be retrieved
by directly contacting all corresponding authors from
published studies on coronary CT versus CCA in
patients with suspected CAD. This will be achieved by
including the primary studies of a recent regular systematic
review and meta-analysis by our working group [13], and
performing an update of this review to identify most recent
studies. A sensitive search strategy using the particular
thesaurus terms of the specific databases in combination
with free text word synonyms [2] will be used to search
MEDLINE (via PubMed), EMBASE (via Ovid) and ISI Web
of Science databases for updating the article pool of rele-
vant studies (suggested search strategies for all databases
are provided in Additional file 1). We will also search
bibliographies of retrieved studies, systematic reviews and
meta-analyses, and include results of abstracts presented at
most recent congresses as suggested by clinical experts.
Key inclusion criteria are a prospective study design; use
of a contemporary CT scanner with at least 12 simultaneous
detector rows; use of ≥50% diameter reduction as the cut-
off criterion for significant coronary artery stenoses in CT
and CCA; application of CCA in all patients, regardless of
the results of CT; provision of individual patient results for
CT and CCA (positive, negative, and nondiagnostic), which
allow calculation of 2×2 (excluding nondiagnostic results)
or 3×2 (including nondiagnostic results) tables [30]; articles
published in English or German; and provision of basic
patient characteristics (age, gender, angina type, heart rate).
Studies with the following characteristics will be
excluded: retrospective study design; overlap with other
studies as indicated by the corresponding author.
Study screening and selection will be performed by two
independent investigators. Retrieved articles will be
searched after duplicate papers (from MEDLINE, EMBASE
and ISI Web of Science) are identified and eliminated. In a
first phase, titles and abstracts will be scanned and, in
accordance with the inclusion and exclusion criteria, either
discarded or retained for further investigation. In a second
phase, the remaining potentially eligible articles will be
reassessed in depth using the full text.
Methodological quality assessment
Two investigators will independently carry out the data
extraction (including quality assessment) from all the
retrieved published studies based on the full text articles.
Discrepancies will be resolved in a consensus meeting,
or, if agreement cannot be reached, they will be resolved
in consensus with a third investigator. To assess and
quantify the inter-rater agreement between the two
investigators in evaluating methodological quality using
the QUADAS tool [31], we will calculate the kappa
statistics. The data extracted will be: general and detailed
methodological study characteristics, characteristics of
the study population, details of the CT technology used,
and detailed reference standard (CCA) specifications.
Collection of individual patient data
An international steering committee of renowned
experts from the field of noninvasive coronary CT angi-
ography has been established to lead, oversee and repre-
sent the CoMe-CCT project. The steering committee
consists of four clinical experts for cardiac CT: Stephan
Achenbach, Erlangen, Germany; Matthew Budoff, Los
Angeles, CA, USA; Mario J Garcia, New York, NY, USA;
Marc Dewey, Berlin, Germany, and one clinical expert
for CCA: Michael Laule, Berlin, Germany. The steering
committee is completed by the project’s statistician Peter
Schlattmann, Jena, Germany.
Corresponding authors of identified eligible published
studies will be contacted using mail including a cover
letter detailing the objectives of the collaborative meta-
analysis, background information on IPD meta-analysis,
and a CD containing a data collection file for input of
individual patient results for the project. The details of the
obligatory and additional patient and study characteristics
are shown in Tables 1 and 2. The filled out data templates
will be send back to us by either mail on CD or, more
conveniently, by email. Further communication will
mainly be performed by email or phone. Corresponding
authors will also be contacted about unpublished data that
will be eligible for inclusion in the collaborative meta-
analysis if the inclusion criteria are met. To further enlarge
the clinical data pool, authors will additionally be asked to
provide data from registries. These data will not be
included in the primary analyses, which are only based on
data from the prospective studies.
Data management, security and validation
The same two investigators who will perform the
electronic database search and identify published eligible
studies for the regular review will also collect and
assemble the IPD provided by the investigators of
published and unpublished studies. Data will be sent as
email attachments to the coordinating investigator of
CoMe-CCT in an anonymized and de-identified way
(without directly identifying information, that is, record
numbers, names, addresses and so on will be removed).
Data will be accepted in any kind of electronic format
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(for example, SPSS, Stata, Word document,) but, ideally,
the investigators will provide the data using the
individualized Microsoft Excel (Microsoft Corp., Redmond,
WA, USA) spreadsheets made available to them. The
original data collection files sent by the authors will be kept
in their original version and will be saved on a password-
protected server behind the firewall in order to ensure
security. Only the coordinating laboratory of CoMe-CCT at
Charité will have direct access to the individual data. Both
investigators will each perform data validation using a copy.
To ensure quality of the data, they will independently
check the received data sets for data entry mistakes and
consistency and will compare the sum of the individual
patient results received with the published summary
results from the primary studies. Differences will be
discussed and settled in consensus, if possible. They will
contact the providing corresponding author in case of
discrepancies that should be resolved.
Outcome measures and statistical analysis
An extension of the exact binomial rendition [32] of the
bivariate mixed-effects regression model developed by
van Houwelingen et al. [33,34] for treatment trial meta-
analysis and modified for synthesis of diagnostic test
data [35,36] will be used for data synthesis. This bivari-
ate statistical model does not transform pairs of positive
and negative predictive values into a single indicator, but
preserves the two-dimensional nature of the data taking
into account any correlation between the two. Given
that we are dealing with individual data, a three-level
bivariate random-effects model will be applied. On the
first level of the model, a binomial distribution will be
assumed for the true positives among the test positives
and the true negatives among the test negatives. On the
second level, the variability between patients within a
certain study will be modeled. Finally, on the third level the
variability between studies will be taken into account.
The primary covariate of interest is the pretest likelihood
of CAD. It will be calculated using a validated prediction
tool [10] based on the original Diamond and Forrester
model for risk calculation [7]. Using this tool, the pretest
likelihood of a patient based on age, gender and clinical
presentation can be estimated. Furthermore, the influence
of covariates such as heart rate and body mass index of
patients as well as the number of CT rows, and the admin-
istration of beta blockade and nitroglycerin, will be taken
into account on the individual patient level. Model selection
will be based on the likelihood ratio test and Bayesian
Information Criterion.
Based on this model, mean logit positive predictive
values and negative predictive values with their standard
error and 95% confidence intervals, estimates of the
between-study variability in logit positive and negative
predictive values, and the covariance between them will
be estimated. These quantities will be back-transformed
to the original scale to obtain summary positive and
negative predictive values. Using this data, a statistical
prediction for a new cohort will be performed following
the ideas presented by Skrondal and Rabe-Hasketh
[37,38]. Estimation will be done with SAS 9.2, Proc
GLIMMIX and STATA 11, using the package GLLAMM.
In addition, for performing a sensitivity analysis, we will
Table 1 Obligatory computed tomography technology and patient characteristics requested in the data file
Computed tomography characteristics Patient and conventional coronary angiography characteristics
Publication from which the data is derived Age and gender, type of symptoms (typical angina pectoris, atypical angina pectoris,
chest pain, no pain, pain unknown)
Results of CT (positivea, negative, nondiagnosticb).
Comment and explanation for nondiagnostic patients
Results of conventional coronary angiography (positivea, negative, nondiagnosticb).
Comment and explanation for nondiagnostic patients
aAt least one ≥50% stenosis in one vessel; bno stenosis in any vessel and at least one vessel not fully evaluable.
Table 2 Additional computed tomography technology and patient characteristics requested in the data file
Additional computed tomography characteristics Patient characteristics and additional tests
Effective radiation dose Weight and height
Type of electrocardiographic gating Derived body mass index
Number of detector rows used Calcium score, heart rate during scanning, presence of cardiac risk factors
(hypertension, diabetes, hyperlipidemia, current or former smoker, positive
family history, prior myocardial infarction)
Beta blockade (type, route, dosage) Results of rest electrocardiography
Nitroglycerin (type, dosage) Results of stress electrocardiography
Contrast agent (type, concentration, flow, amount) Results of stress echocardiography
Breath hold duration Results of stress scintigraphy
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also use WinBUGS [39]. If necessary, macros will be
written to facilitate the use of three-level generalized
linear mixed-effects models.
Based on the model described above, mean logit
sensitivity and specificity with their standard error
and 95% confidence intervals, estimates of the between-
study variability in logit sensitivity and specificity, and the
covariance between them will be estimated. These
quantities will be back-transformed to the original
ROC (Receiver Operating Characteristic) scale to obtain
summary sensitivity, specificity and the diagnostic odds
ratios. The derived logit estimates of sensitivity, specificity
and respective variances are then used to construct a
hierarchical summary ROC curve for CT with summary
operating points for sensitivity and specificity on the
curves and a 95% confidence contour ellipsoid.
Here the individual patient-specific covariates such as
type and severity of symptoms, body mass index, beta
blockade and sublingual nitroglycerin will be used in the
regression analysis. This serves as tool to identify
spectrum bias and clinically relevant influential factors.
For performing sensitivity analysis, the analysis will be
redone by leaving out one study. The generalized linear
mixed model is known to be sensitive to starting values.
Thus an additional analysis with Bayesian methods using
PROC MCMC, SAS 9.2 will be performed.
Discussion
We believe that this collaborative multi-centric and
multi-continental IPD meta-analysis will have an important
impact on the clinical management of patients with
suspected CAD as it should provide an answer to the
question of which patients benefit most from coronary
CT angiography. Furthermore, additional factors that
influence the diagnostic performance of CT in comparison
to CCA can be identified in this meta-analysis. This IPD
meta-analysis also holds the potential to analyze and
compare the predictive value of cardiac CT and CCA for
subsequent major adverse cardiovascular events. Finally,
the CoMe-CCT may facilitate the adequate selection of
patients for cardiac CT by estimating the pretest likelihood
for disease and predicting the diagnostic performance for
individual patients that should ultimately help to avoid
unnecessary examinations and thus decrease the use of
scarce health care resources in the future [40].
Trial status
Currently, in the course of performance of the IPD
meta-analysis, we are in the state of data collection and
data validation. No statistical analysis has yet been
performed. The update search still has to be performed
to be able to identify most recent articles and to contact
the corresponding authors. At the time of study protocol
submission, 54 single data sets from 40 authors and
including more than 5,500 IPD comparing CT and CCA
have been acquired.
Additional file
Additional file 1: Search Strategies for MEDLINE, EMBASE and ISI
Web of Science.
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